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HIVANPodocyte damage induced by HIV-1 is critical to the pathogenesis of HIV-1 associated nephropathy (HIVAN)
and is believed to result from productive replication of the virus. Here we demonstrate that HIV-1 readily
enters human podocytes by a dynamin-mediated endocytosis but does not establish productive infection. We
provide evidence suggesting that viral nucleic acids and proteins detected in podocytes are delivered by viral
particles internalized by the cells. Endocytosed HIV-1 is only transiently harbored by podocytes and is
subsequently released to the extracellular milieu as fully infectious virus. Similarly, primary podocytes
established from normal human urine do not support productive infection by HIV-1 but sustain replication of
VSV-G pseudotyped virus that bypasses HIV-1 entry receptors. Moreover, transfected podocytes expressing
CD4 and CXCR4 receptors support productive replication of HIV-1. This further conﬁrms that lack of HIV-1
entry receptors is the major barrier preventing productive infection of podocytes in vitro.ll rights reserved.© 2010 Elsevier Inc. All rights reserved.Introduction
Podocytes are the key components of the glomerular ﬁltration
barrier and podocyte injury leads to loss of integrity of the barrier and
proteinuria. The pathogenesis of HIV-1 associated nephropathy
(HIVAN) is poorly understood. Although HIVAN affects all compart-
ments of the kidney including the tubular epithelium (Bruggeman
et al., 2000), infection of podocytes seems to be critical to HIVAN
pathogenesis (Yang et al., 2002). HIV-1 infection of podocytes was
shown to stimulate podocyte dedifferentiation, proliferation and loss
of the majority of podocyte-speciﬁc markers (Lu et al., 2007). It has
been reported that the virus remains transcriptionally active in the
kidney of patients on highly active antiretroviral therapy with
undetectable blood plasma viremia (Bruggeman et al., 2000; Winston
et al., 2001), suggesting that the renal epithelium may represent a
distinct HIV-1 reservoir. Further support for the replication of HIV-1 in
renal epithelium comes from the observation that viral envelope
gp120 evolves differently in peripheral blood and the renal compart-
ment (Marras et al., 2002). Since renal epithelial cells do not express
classical HIV-1 entry receptors (Huber et al., 2002), the mechanism by
which HIV-1 infects the renal epithelium remains unclear. The C-type
lectin DEC-2005 was recently proposed to mediate infection of renal
HK2 proximal tubular cells, however this entry route also leads to
non-productive infection (Hatsukari et al., 2007; Mikulak et al., 2009).
There is compelling evidence that expression of viral proteins Nef
and/or Vpr in immortalized podocytes (Husain et al., 2002; Lu et al.,2008; Sunamoto et al., 2003) or in transgenic animal models of HIVAN
(Husain et al., 2005; Rosenstiel et al., 2009; Zuo et al., 2006) is
sufﬁcient to induce the podocyte dysfunction observed in HIVAN.
Since Nef and Vpr were expressed from transfected HIV-1 constructs,
it is unclear whether these proteins would be expressed in podocytes
infected with wild-type HIV-1. Although detection of HIV-1 nucleic
acids in glomerular podocytes in HIVAN kidney biopsy samples seems
to indicate that these cells can be productively infected with HIV-1
in vivo (Bruggeman et al., 2000; Marras et al., 2002), themechanism of
this process remains undetermined.
To gain insights on thepermissiveness of podocytes to infectionwith
wild-type HIV-1, we investigated replication of HIV-1 in podocytes
in vitro. In our approach, we used both conditionally immortalized
podocyte cells AB8/13 (Saleem et al., 2002) and primary podocytes
isolated from the urine of healthy donors. We demonstrate that despite
HIV-1 particles being readily internalized by podocytes, this process
does not lead to productive infection.We further demonstrate that viral
nucleic acids and proteins detected in podocytes originate from
endocytosed viral particles rather than productive replication of HIV-1
in podocytes. We also show that lack of HIV-1 entry receptors in
podocytes is a key barrier to productive infection and can be overcome
by the exogenous expression of HIV-1 receptors in podocytes.
Results
HIV-1AD8 is internalized by human AB8/13 podocytes
The major objective of this study was to establish whether wild-
type HIV-1 can establish productive infection in human podocytes in
vitro. HIV-1 entry into conditionally immortalized and differentiated
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confocal microscopy using macrophage-tropic (R5) HIV-1 AD8. To
enable the monitoring of viral particles that entered cells, HIV-1 was
labeled with GFP-Vpr fusion protein that localizes to the virus core
(Campbell et al., 2007). Confocal microscopy images (Fig. 1A) show
that ﬂuorescently labeled HIV-1 efﬁciently entered AB8/13 podocytes
and partially colocalized with markers speciﬁc for late endosomes/
lysosomes (LysoTracker, LT) and early/recycling endosomes (Trans-
ferrin, TF). This suggests that a fraction of endocytosed virus may be
degraded in podocytes or recycled back to the cell surface and
released to the cellular environment. To investigate virus entry in
more detail, we used a 100-fold lower input of HIV-1 AD8. Our results
conﬁrmed that ﬂuorescent virus particles partially colocalized with
LysoTracker and Transferrin in podocytes (Fig. 1C) as well as in TZM-Fig. 1.HIV-1 enters podocytes by a dynamin-dependent endocytosis. (A) Differentiated AB 8
and incubated for 30 minwith LysoTracker Red (LT, 50 nM) or Transferrin-Alexa Fluor 594 (T
were pretreated for 1 h with 200 μMdynasore in 0.1% DMSO (+Dynasore) or with 0.1% DMS
entry and Transferrin-Alexa Fluor 594 uptake in the absence or presence of dynasore are show
in Figs. 1A and B) with LysoTracker Red (LT) and Transferrin-Alexa Fluor 594 (TF) in podocbl cells that express HIV-1 receptors and support productive infection
(Fig. 1D). A speciﬁc dynamin inhibitor, dynasore (Macia et al., 2006;
Miyauchi et al., 2009), potently reduced virus entry and transferrin
uptake into podocytes (Fig. 1B), indicating that dynamin-mediated
endocytosis plays a key role in virus entry into podocytes.
HIV-1 DNA accumulating in podocytes is delivered by endocytosed viral
particles
Virus endocytosis often leads to non-productive infection of CD4-
negative cells (Dezzutti et al., 2001; Vacharaksa et al., 2008). However,
coexistence of endocytic entry with productive infection was also
observed (Vidricaire andTremblay, 2007). Thus, to determinewhether
HIV-1 replicates productively in podocytes, we analyzed accumulation/13 podocytes were incubated for 90 min with ﬂuorescently labeled HIV-1 AD8, washed
F, 5 μg/ml). Separate andmerged confocal microscopy images are shown. (B) Podocytes
O alone (−Dynasore) and infected with AD8 as described in (A). Confocal images of AD8
n. (C, D) Colocalization of HIV-1 particles (multiplicity of infection 100-fold lower than
ytes (C) and TZM-bl cells susceptible to HIV-1 infection (D).
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Fig. 2. Accumulations of HIV-1 reverse transcription products in infected podocytes and HIV-1 virions. (A) Differentiated AB8/13 podocytes were infected for 3 h with DNase I-
treated NL4-3, washed, and total DNA isolated immediately after infection (3 h) and again after the indicated times. The levels of ERT, LRT and 2-LTR circles were quantiﬁed by real-
time PCR and normalized against GAPDH. PCR conditions and oligonucleotide primers are described (Khatua et al., 2009). Relative expression levels were compared by setting the
level of ERT at 3 h post-infection to 100%. Control, uninfected podocytes. (B, C) The cells were pretreated for 1 h with a mixture of AZT (50 μM) and 3TC (50 μM) (RTI). Infection with
NL4-3 (B) or VSV-G pseudotyped NL4-3 (C) was performed in the presence of RTI. The level of ERT at 3 h post-infection without RTI was set to 100%. (D) Total DNA isolated from AD8
virions was analyzed for the expression of ERT and LRT. The expression of ERT was set to 100%. The levels of ERT and LRT DNA in uninfected podocytes (control) were undetectable
(UD). (E, F) Heat-inactivated HIV-1 does not enter podocytes. Native NL4-3 (NL wt) or NL4-3 inactivated for 1 h at 65 °C (Mbisa et al., 2007) or treated with aldrithiol-2 (AT-2) that
preserves conformational and functional integrity of virion surface proteins (Rossio et al., 1998) were exposed to podocytes for 3 h. At indicated times, expression of ERT (E) or viral
p24 (F) were analyzed by real-time RT-PCR or Western blotting, respectively. ERT and GAPDH copy numbers were calculated using standard curves generated from 1 to 1×107
copies of respective plasmid DNAs. Error bars, means±SDs of triplicate samples from one experiment.
121A.K. Khatua et al. / Virology 408 (2010) 119–127of HIV-1 reverse transcription DNA products in podocytes infected
with T-tropic (X4) HIV-1 NL4-3 (Fig. 2A). HIV-1 early reverse
transcription (ERT) and late (LRT) DNA products peaked at 3 h post-
infection (the earliest time point analyzed) and rapidly diminished
thereafter. Expression of ERT, LRT and 2-LTR circles was undetectable
between 2 and 7 days post-infection (last time point analyzed). A
similar pattern of ERT and LRT expression was also observed for AD8
(not shown). To investigate whether ERT and LRT were de novo
synthesized in podocytes, we used a mix of two reverse transcription
(RT) inhibitors, AZT and 3TC. The expression of ERT and LRT in the
presence of RT inhibitors was unchanged, indicating that ERT and LRT
were not synthesized de novo but rather were delivered by viral
particles captured by podocytes (Fig. 2B). Indeed, we have detected
both ERT and LRT in puriﬁed and DNase I-treated HIV-1 virions
(Fig. 2D). These results support previous observations demonstratingthe presence of HIV-1 DNA species inside HIV-1 virions (Houzet et al.,
2007a,b). As expected, replication of NL4-3 pseudotyped with VSV-G
envelope that directs the delivery of the viral core into the cytoplasm
(a prerequisite for productive infection) was sensitive to RT inhibitors
(Fig. 2C), suggesting that AZT and 3TCwere functional in podocytes. To
investigate whether virus entry is receptor-mediated, the virus was
inactivated by incubation for 1 h at 65 °C or treatmentwith aldrithiol-2
(AT-2), known to preserve conformational integrity of virion surface
proteins (Rossio et al., 1998) (Fig. 2E). Results demonstrate that
accumulation of ERT in podocytes at 3 h and 6 h post-infection was
severely reduced (13–15-fold) in heat-treated virions but only
marginally reduced in AT-2-treated virions. Western blot analysis
(Fig. 2F) conﬁrmed results obtained using real-time PCR. Together,
these results suggest that non-productive entry of HIV-1 into podocytes
is speciﬁc.
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Fig. 3. Expression ofNef2mRNA in infectedpodocytes andHIV-1 virions. (A)Differentiated
podocytes were infected with NL4-3 ΔEnv virions pseudotyped with HXB2 or VSV-G
envelopes. At indicated times, cellular RNA was isolated, reverse transcribed and
analyzed by real-time RT-PCR. Expression of Nef2 mRNA was normalized to GAPDH and
the level ofNef2mRNAat3 hpost-infectionwithHXB2pseudotypedHIV-1was set to 100%.
(B)Relative expression of genomic unspliced (usRNA)RNA,multiply spliced RNA (msRNA)
and Nef2 mRNA in AD8 virions were quantitated and normalized against 7SL RNA
(Onafuwa-Nuga et al., 2006). Expression of virion usRNA was set to 100%.
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Active replication of HIV-1 can also be assessed by the accumu-
lation of viral transcripts in infected cells. Since doubly spliced Nef2Fig. 4. Immunoblot analysis ofHIV-1proteins expressed inpodocytes and releasedvirions. Podo
G envelopes. Cellular lysates (Cells) were prepared at indicated times and analyzed byWestern
cellswerewashed 5 times and virus particles released from infectedcellswere sedimented from
6 h and 24 h (24 h), and between 24 h and 48 h post-infection (48 h) (Virus). Pelleted virionsmRNA is produced at high levels early in infection, we have quantiﬁed
accumulation of Nef2 mRNA using real-time RT-PCR (Dowling et al.,
2008). We have found that in podocytes infected with X4 HXB2-
pseudotyped virus, Nef2 mRNA accumulated transiently followed
by about 70-fold reduction at 24 h post-infection. In contrast, in
podocytes infected with VSV-G-pseudotyped HIV-1, Nef2 mRNA
levels at 24 h post-infection increased 522-fold over the level detected
at 3 h post-infection (Fig. 3A). These results suggest that HIV-1
pseudotyped with VSV-G, but not with HXB2 envelope, replicated
in infected podocytes. Similar levels of Nef2 mRNA detected at 3 h
post-infection with VSV-G- or HXB2-pseudotyped HIV-1 indicate that
endocytosed virions were the source of Nef2 mRNA accumulated
in podocytes. In line with earlier observations showing that HIV-1
virions incorporate detectable amounts of singly and fully spliced
mRNAs coding for Tat, Rev and Nef (Houzet et al., 2007a,b; Liang et al.,
2004; Pasternak et al., 2008), we have detected low levels of
Nef2 mRNA and multiply spliced RNA (msRNA) in AD8 virions
(Fig. 3B).
HIV-1 Gag accumulates transiently in HIV-1 infected podocytes
Synthesis of viral structural and accessory proteins is another
hallmark of productive HIV-1 infection. Therefore, we have investi-
gated whether podocytes infected with different tropism viruses
express HIV-1 Gag and accessory Nef protein implicated in podocyte
injury (Atta et al., 2008; He et al., 2004; Husain et al., 2002, 2005;
Sunamoto et al., 2003; Zuo et al., 2006). HIV-1 Gag p24 was detected
at 3 h post-infection in podocytes infected with all analyzed viruses
(Fig. 4). However, at 6 h post-infection, the levels of intracellular p24
were markedly reduced (10–20-fold). This correlated with release of
pelletable p24 (viral particles) into the supernatant by cells infected
with NL4-3, AD8 or HXB2-pseudotyped virus. In contrast, virus-like
particles (VLPs) secreted by cells infected with VSV-G pseudotyped
HIV-1 were detectable in the supernatant at 48 h post-infection.
Analysis of Gag p24 in podocytes infectedwith X4 or R5 HIV-1 showed
no accumulation of Gag p24 between 2 and 8 days post-infection
(not shown). Intracellular expression of Nef proteinwas detected only
in podocytes infected with VSV-G pseudotyped virus at 48 h post-
infection and coincided with the release of VLPs. In summary, viral
Gag proteins detected early in infection did not reﬂect productive
infection but originated from virions captured by podocytes.cyteswere infected for 3 hwithNL4-3,AD8orNLΔE-EGFPpseudotypedwithHXB2orVSV-
blotting for the expression of HIV-1 Gag (p24, p55), Nef, and actin. After 3 h infection, the
the samevolumeofmedia (6 ml) collected between3 h and6 h (denoted as 6 h), between
were analyzed by immunoblotting for the expression of HIV-1 Gag.
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We have next analyzed the infectivity of the virus released from
infected podocytes. Input HIV-1 and virus recovered from podocytes
between 6 and 24 h post-infection were normalized by RT assay and
the same amount of virus was tested on TZM-bl reporter cells (Fig. 5).
We demonstrate that AD8 virus released from podocytes (AD8
recovered) retained infectivity similar to the input virus. Thus, virus
retained in podocytes could potentially disseminate HIV-1 to suscep-
tible cells.
Podocytes expressing CD4 and CXCR4 become susceptible to productive
infection
Lack of expression of HIV-1 entry receptors by podocytes
(Eitner et al., 2000; Huber et al., 2002) is likely to be the major
barrier that prevents productive replication of HIV-1 in these cells.
Therefore, we have tested whether expression of CD4 and CXCR4 in
podocytes would lead to productive infection. In this experiment,
we used undifferentiated podocytes that can be transfected more
efﬁciently than differentiated cells. We have found that undiffer-
entiated podocytes transfected with CD4 and CXCR4 expression
vectors supported productive replication of NL4-3, as demonstrat-
ed by cellular accumulation of ERT, LRT, 2-LTR (Fig. 6A) and p24
Gag, and release of viral particles (Fig. 6B). In contrast, untrans-
fected and undifferentiated podocytes did not support productive
NL4-3 replication and only transiently accumulated viral DNA and
Gag.
To investigate whether differentiated podocytes express HIV-1
entry receptors, we analyzed by real-time RT-PCR the expression of
CD4, CXCR4 and CCR5 mRNAs by AB8/13 and primary urinary
podocytes (see Fig. 7) and compared it with the expression of the
receptor mRNAs by activated blood-derived CD4+ T cells (Khatua
et al., 2009). Results (Fig. 6C) show that in contrast to CD4+ T cells,
differentiated AB8/13 and urinary podocytes have undetectable
expression of CCR5 mRNA and negligible expression of CD4 and
CXCR4 mRNAs.
Urinary podocytes do not support HIV-1 replication
Recently, viable podocytes have been isolated from human
(Sakairi et al., 2010; Vogelmann et al., 2003) and rat (Petermann
et al., 2003; Yu et al., 2005) urine. Interestingly, human urinary
podocytesmay potentially represent a novelmodel of renal podocyte
diseases that can be established without need for invasive renal
biopsy. We have thus investigated whether urinary podocytes from
normal donors support HIV-1 replication. The cells were isolated
from the urinary pellets and cultured for about 4 weeks to allow forFig. 5. HIV-1 released from infected podocytes is infectious. (A) AD8 added to differentiated
infection (AD8 recovered) were tittered and the same amount of viral inoculum (RT assay s
dilutions of viral inoculum were applied: 105, 104, and 103 RT cpm. After 2 days, cells wer
inoculum (105 RT cpm) applied to indicator cells is shown. Control, uninfected TZM-bl cells. (
means±SDs of triplicate samples from one experiment.differentiation and expression of markers characteristic for differ-
entiated podocytes. Urinary cells cultured on collagen I coated dishes
showed morphology typical for differentiated podocytes (Fig. 7A).
Using real-time RT-PCR, we have detected expression of several
podocyte-speciﬁc genes (Fig. 7B), however the expression of podocin
mRNAwas undetectable (Sakairi et al., 2010). Expression of aquaporin-
1 (AQP1), AQP2, epithelial sodium channel β (ENACβ) and von
Willebrand factor (VWF) mRNAs were not detected, conﬁrming that
these cells were not detectably contaminated with proximal tubular
cells, collecting duct or endothelial cells. Immunoﬂuorescent staining of
vimentin, podocalyxin, synaptopodin, CD35, and WT-1 (not shown)
further veriﬁed that urinary cells had characteristics of differentiated
podocytes.
As observed with glomerular AB 8/13 podocytes, urinary podo-
cytes infected with HIV-1 AD8 showed only a transient accumulation
of HIV-1 ERT, LRT and Gag p24 (Figs. 7C,D). This suggests that HIV-1
infection was non-productive and detected HIV-1 DNA and p24
were delivered to urinary podocytes by internalized virions. To rule
out the possibility that cultured urinary podocytes do not support
virus replication for reasons other than lack of HIV-1 entry receptors
(Fig. 6C), the cells were infected with VSV-G pseudotyped NL4-3
ΔEnv-EGFP (Zhang et al., 2004). Results show that HIV-1 pseudotyped
with VSV-G envelope, which bypasses HIV-1 entry receptors,
replicates in urinary podocytes, as demonstrated by the accumulation
of truncated Env-EGFP fusion protein (Fig. 7E).
Discussion
The mechanism of HIV-1 entry and podocyte infection is critical to
HIVAN pathogenesis and for the development of novel therapies
preventing infection or damage of podocytes. Although existing data
suggest the possibility of infection of podocytes by HIV-1 in vivo, there
is no data from in vitro studies that could conﬁrm these observations
and provide insights on the mechanism of podocyte infection. There-
fore, in this study we investigated whether podocytes in vitro can be
productively infected with wild-type HIV-1. We have demonstrated
that podocytes efﬁciently internalize ﬂuorescently labeled HIV-1
particles through a dynamin-dependent process independent of
virus tropism. It is likely that to internalize HIV-1, podocytes use an
existing and highly efﬁcient endocytic activity (Eyre et al., 2007;
Ina et al., 2002; Rastaldi et al., 2006) that normally plays an essential
role in podocyte physiology and maintenance of the healthy
glomerular ﬁlter (Akilesh et al., 2008). Further, we have shown that
HIV-1 internalization requires intact virion surface proteins, suggest-
ing that HIV-1 internalization is mediated by the interaction of
virus with a speciﬁc receptor expressed by podocytes. Indeed,
while our manuscript was under review, a report addressing the
replication of HIV-1 in podocytes was published (Mikulak et al.). TheAB8/13 podocytes (AD8 input) and released from podocytes between 6 and 24 h post-
tandardized) was added in triplicate to TZM-bl indicator cells in a 12-well plate. Three
e ﬁxed and stained for β-galactosidase and positive syncytia were counted (B). Viral
B) Percent infectivity is presented relative to infectivity of input virus (100%). Error bars,
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124 A.K. Khatua et al. / Virology 408 (2010) 119–127authors conﬁrmed our observations that HIV-1 enters podocytes
by endocytosis without establishing a productive infection. Further-
more, the authors demonstrated that HIV-1 internalization was
mediated by DC-SIGN, a receptor that functions as an attachment
factor of HIV-1 and facilitates dendritic cell-mediated viral transmis-
sion (Geijtenbeek et al., 2000a,b).
To investigate whether internalization of the virus leads to
productive infection of podocytes, we performed a time-course
analysis of cellular accumulation of viral nucleic acids and proteins.
We have shown that RT inhibitors had no effect on the levels of ERTand LRT in podocytes, indicating that it is unlikely that these
transcripts were synthesized in infected podocytes. Indeed, we
have detected ERT and LRT in viral particles, suggesting that HIV-1
DNA could be delivered by endocytosed particles. Detection of
several viral DNA species inside HIV-1 virions (Houzet et al., 2007a,b)
further supports this conclusion. In addition, HIV-1 virions were
shown to accumulate also singly and fully spliced mRNAs coding
for Tat, Rev and Nef (Houzet et al., 2007a,b; Liang et al., 2004;
Pasternak et al., 2008). Indeed, we have detected Nef2 mRNA in AD8
virions and in infected cells. However, in contrast to podocytes
productively infected with VSV-G pseudotyped HIV-1, Nef2 mRNA
quickly disappeared from cells infected with HIV-1 expressing HXB2
envelope.
Immunoblot analysis of HIV-1 Gag in cell lysates and culture
supernatants from podocytes infected with wild-type HIV-1 indicates
that a transient accumulation of Gag resulted from endocytic uptake
of the virus that was subsequently released into the culture medium.
Moreover, the virus released into the extracellular milieu was fully
infectious, suggesting that podocytes in vivo may transiently accu-
mulate HIV-1 and disseminate it to susceptible cells (Hatsukari et al.,
2007; Mikulak et al., 2009).
To expand our observations beyond conditionally immortalized
glomerular podocytes, we have also examined HIV-1 infection of
primary podocytes isolated from the urine of normal donors. Recently,
viable podocytes have been isolated from human (Sakairi et al., 2010;
Vogelmann et al., 2003) and rat (Petermann et al., 2003; Yu et al.,
2005) urine. Urinary podocytes show originally a dedifferentiated
phenotype and express very few markers typical for podocytes.
However, after about 3–4 weeks in culture, podocytes expressed the
majority of protein and mRNA markers typical for differentiated
podocytes. As reported earlier, podocin mRNA was usually undetect-
able in urinary podocytes (Sakairi et al., 2010). Using this model, we
have conﬁrmed that urinary podocytes did not support HIV-1
replication, although the cells were susceptible to infection with
VSV-G pseudotyped HIV-1.
Several reports (Husain et al., 2002, 2005; Lu et al., 2008;
Sunamoto et al., 2003; Zuo et al., 2006) convincingly showed that
expression of viral proteins Nef or Vpr in podocytes leads to podocyte
injury, supporting a view that expression of viral proteins is crucial
for podocyte injury. Although these approaches are informative,
expression of viral proteins in podocytes infected with viruses
pseudotyped with VSV-G or transfected with HIV-1 constructs may
lead to overexpression of viral proteins and non-speciﬁc effects.
To reconcile our in vitro results, obtained using two different
sources of podocytes, with observations in vivo suggesting productive
infection of podocytes, we hypothesize the existence of mechanism(s)
in vivo that could overcome the lack of HIV-1 entry receptors in
podocytes and help to establish productive infection. One of the
possible mechanisms is transfer of HIV-1 receptors via exosomes
secreted by CD4-positive cells. In the present study, we have shown
that expression of CD4 and CXCR4 in podocytes confers susceptibility
to HIV-1 infection. Our previous results demonstrate that cells
expressing CD4 and CXCR4 incorporate these receptors into secreted
exosomes (Khatua et al., 2009). Similarly, transfer of CCR5 (Mack
et al., 2000) or CXCR4 (Rozmyslowicz et al., 2003) by microvesicles to
CCR5- or CXCR4-deﬁcient cells, respectively, was shown to allow for
virus replication in these cells. Another possibility is that viral proteins
that damage podocytes may be transferred to podocytes by exosomes
released from infected cells. Indeed, accumulation of functional Nef
in exosomes released from infected T cells has been documented
(Ali et al., 2010; Lenassi et al., 2010; Muratori et al., 2009). This
suggests that limited replication of HIV-1 in podocytes combinedwith
toxic effects of exosomes carrying Nef could produce extensive
damage to podocytes. Thus, it is conceivable that exosomes may play
an essential role in infection of podocytes by HIV-1 in vivo and may
provide new insights into the pathogenesis of HIVAN.
Fig. 7. Urinary podocytes do not support replication of HIV-1. (A) Urinary cells from a healthy volunteer cultured for about 4 weeks display morphology of differentiated podocytes
and (B) express podocyte-speciﬁc mRNAs detected in real-time RT-PCR (Rahmoune et al., 2005; Sakairi et al., 2010; Schmid et al., 2003). Ampliﬁed PCR products were resolved on 2%
agarose gels and visualized with ethidium bromide. (C) Urinary podocytes were infected with AD8 for 3 h, extensively washed and cultured for the indicated times. Relative
expression of ERT, LRT and 2-LTR circles (normalized against GAPDH) were compared by setting the level of ERT at 3 h post-infection to 100%. (D) Transient expression of HIV-1 Gag
proteins in urinary podocytes coincides with a transient release of HIV-1 virions (pelletable p24) into culture medium. (E) Accumulation of truncated Env-EGFP fusion protein
indicates replication of VSV-G pseudotyped NL4-3 ΔE-EGFP (Zhang et al., 2004) in urinary podocytes.
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Podocyte culture
Undifferentiated conditionally immortalized human podocytes
AB8/13 (Saleem et al., 2002) were cultured at 33 °C in RPMI medium
supplemented with 10% FCS (RPMI-10% FCS), penicillin and strepto-
mycin, and insulin–transferrin–selenium (ITS) (Invitrogen) on 6-well
plastic dishes covered with collagen I (Invitrogen). Podocyte differ-
entiation was achieved by growing the cells for 14 days at 37 °C to
inactivate temperature-sensitive SV40 large T antigen (U19tsA58).
Urine samples were obtained from consented healthy volunteers,
after the research protocol was approved by Meharry Medical
College's IRB. A fresh urine sample was centrifuged for 10 min at
700×g and the urinary pellet was washed twice with RPMI 1640 and
centrifuged. The pelleted cells, resuspended in RPMI-10% FCS
supplemented with penicillin, streptomycin and ITS were seeded on
60 mm plastic dishes coated with collagen I. The following day,
the media with unattached cells and debris were replaced with
fresh culture media. After about 7–14 days, the cells were trypsinized
for about 1.5–2 min and cells that easily detached from culturedishes were transferred to new plates coated with collagen I.
After one or two additional subculturing cycles (about 4 weeks in
culture), the cells were analyzed by real-time RT-PCR and immuno-
ﬂuorescence to conﬁrm the expression of podocyte-speciﬁc mRNAs
and proteins.
Virus preparation
Virus stocks were prepared by transfecting 293T cells with HIV-
1 plasmid DNA by using PolyFect reagent (Qiagen) as described
(Khatua et al., 2009). Puriﬁed and concentrated virus was treatedwith
DNase I (300 U/ml) for 30 min at 37 °C and for 1 h at room temper-
ature, tittered by p24 ELISA assay or by the reverse transcriptase
activity assay (Popik and Pitha, 2000). HIV-1 aliquots were stored at
−80 °C.
Virus inactivation
Heat inactivation was carried out for 1 h at 65 °C as described
(Mbisa et al., 2007). For inactivation with aldriothiol-2 (AT-2), a stock
solution of AT-2 (100 mM in dimethyl sulfoxide, DMSO) was added
126 A.K. Khatua et al. / Virology 408 (2010) 119–127to virus to a ﬁnal concentration of 1 mM (in 300 μl) and incubated
for 1 h at 37 °C. Control virus (native NL4-3) was exposed to DMSO
alone. After the treatment, virus preparation was diluted to 11 ml
with RPMI-10%FCS and concentrated by ultracentrifugation. Pelleted
virus was resuspended in the original volume of RPMI-10%FCS and
used immediately in experiments.
Viral infectivity assay
HIV-1 AD8 was added to differentiated AB8/13 podocytes (AD8
input) and incubated for 3 h. After extensive washing (5 washes
with RPMI 1640), the cells were incubated for an additional 3 h,
washed again 3 times and virus released from podocytes between 6
and 24 h post-infection (AD8 recovered) was collected and tittered.
The same amount of input and recovered viral inoculum (standard-
ized by RT assay) was added in triplicate to TZM-bl indicator cells in a
12-well plate according to the protocol (NIH AIDS Research and
Reference Reagent Program; cat no. 1470). After 2 days, cells were
ﬁxed and stained for β-galactosidase and positive syncytia (blue)
were counted.
Confocal microscopy
Differentiated AB8/13 podocytes were incubated at 37 °C for
90 min with HIV-1 AD8 ﬂuorescently labeled with GFP-Vpr (Liu et al.,
2002), washed and incubated for 30 min with LysoTracker Red
(50 nM) (Invitrogen) or Transferrin-Alexa Fluor 594 (5 μg/ml)
(Invitrogen). When indicated, the cells were pretreated for 1 h with
200 μM dynasore (Tocris Bioscience) (Macia et al., 2006) in 0.1%
DMSO or with 0.1% DMSO alone and subsequently infectedwith HIV-1
in the presence or absence of dynasore. The cells were washed, ﬁxed
in 4% paraformaldehyde for 15 min, washed and mounted with
ProLong antifade reagent (Invitrogen) and observed under a laser
scanning confocal microscope (Nikon TE2000).
Immunoblot analysis
Cellular lysates were prepared from uninfected or HIV-1 infected
differentiated podocytes growing in 6-well plates. Cell culture
supernatants from 3 wells (6 ml) were collected at different time
points, ﬁltered through 0.45-μm ﬁlter and viral particles were
sedimented by ultracentrifugation for 1 h at 100,000×g and lysed
in SDS lysis buffer. Proteins (30 μg/lane) were separated on SDS-
10% polyacrylamide gels and analyzed as described (Khatua et al.,
2009). Monoclonal p24 and rabbit Nef antibodies were obtained
through the NIH AIDS Research and Reference Reagent Program,
Division of AIDS, NIAID, NIH. Rabbit anti-actin antibody was from
Sigma.
Quantitative analyses of HIV-1 reverse transcription products
Differentiated AB8/13 podocytes or urinary podocytes growing
in 6-well plates were infected for 3 h at 37 °C with DNase I-treated
viruses (total 100 ng p24/plate), washed 5 times with PBS, and total
DNA was isolated immediately after infection (3 h) or after the
indicated times. Total DNA was puriﬁed using a DNeasy kit (Qiagen).
In experiments with reverse transcription inhibitors (RTI), the cells
were pretreated for 1 h with 50 μM zidovudine (AZT) and 50 μM
lamivudine (3TC). Infection and subsequent cell cultivation was
performed in the presence of RTI. The levels of early (ERT) and late
(LRT) reverse transcripts and 2-LTR circles were quantiﬁed by real-
time PCR and normalized against GAPDH. PCR conditions and
oligonucleotide primers were described (Khatua et al., 2009).
Standard curves were generated using plasmids containing HIV-1
DNA (pNL4-3-deltaE-EGFP, NIH AIDS Research and Reference Reagent
Program #11100) and GAPDH cDNA (OriGene).RNA preparation, cDNA synthesis and real-time RT-PCR
Total RNA was isolated using total RNA puriﬁcation kit (Norgen).
RNA was treated with Turbo DNase (Ambion) and 1 μg RNA was
reverse transcribed using iScript cDNA synthesis kit (Bio-Rad) and
subjected to real-time-PCR using conditions and primers for podo-
cyte-speciﬁc and non-speciﬁc genes (Rahmoune et al., 2005; Sakairi
et al., 2010; Schmid et al., 2003). Ampliﬁed PCR products were
resolved on 2% agarose gel and visualized with ethidium bromide.
Real-time PCR conditions and primers to detect HIV-1 unspliced
genomic RNA and multiply spliced RNA (Pasternak et al., 2008) and
Nef2 mRNA (Dowling et al., 2008) are described elsewhere,
respectively.
Statistical analysis
Unless stated otherwise, all experiments were performed at least
three times. The variation in one experiment was expressed by
calculating standard deviation (SD) from the triplicates and presented
as the mean value±SD.
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